Parabilis Medicines, Inc. (PBLS) Form 10-K Annual Reports
Parabilis Medicines, Inc. (PBLS) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: PBLS
CIK: 1657677
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
PricewaterhouseCoopers LLP
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerStephen DeMarco
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-09-15 | 2026-09-15 | 8-K | 0001193125-26-391952 | View SEC Doc Filr Page |
| 8-K | 2026-09-02 | 2026-08-28 | 8-K | 0001193125-26-380171 | View SEC Doc Filr Page |
| 4 | 2026-08-25 | 2026-08-22 | 4 | 0001193125-26-365484 | View SEC Doc Filr Page |
| 3 | 2026-08-25 | 2026-08-22 | 3 | 0001193125-26-365459 | View SEC Doc Filr Page |
| 8-K | 2026-08-25 | 2026-08-22 | 8-K | 0001193125-26-365132 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-14 | — | SCHEDULE 13G Filing | 0001193125-26-352189 | View SEC Doc Filr Page |
| 10-Q | 2026-08-13 | 2026-06-30 | 10-Q | 0001193125-26-349168 | View SEC Doc Filr Page |
| 8-K | 2026-08-13 | 2026-08-13 | 8-K | 0001193125-26-347869 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-06 | — | SCHEDULE 13G Filing | 0000315066-26-002123 | View SEC Doc Filr Page |
| 4 | 2026-07-22 | 2026-07-20 | 4 Filing | 0001231919-26-000779 | View SEC Doc Filr Page |
| 4 | 2026-06-29 | 2026-06-11 | 4 Filing | 0001213900-26-072928 | View SEC Doc Filr Page |
| 3 | 2026-06-29 | 2026-06-09 | 3 Filing | 0001213900-26-072925 | View SEC Doc Filr Page |
| SCHEDULE 13D | 2026-06-18 | — | SCHEDULE 13D Filing | 0001346824-26-000178 | View SEC Doc Filr Page |
| 4 | 2026-06-16 | 2026-06-12 | 4 | 0001193125-26-273013 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-11 | 4 Filing | 0001231919-26-000638 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-09 | 4 | 0001193125-26-271344 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-11 | 4 | 0001193125-26-271324 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-11 | 4 | 0001193125-26-271300 | View SEC Doc Filr Page |
| 4 | 2026-06-11 | 2026-06-11 | 4 Filing | 0001193805-26-000798 | View SEC Doc Filr Page |
| 4 | 2026-06-11 | 2026-06-09 | 4 Filing | 0001231919-26-000623 | View SEC Doc Filr Page |
| 4 | 2026-06-11 | 2026-06-09 | 4 | 0001193125-26-267806 | View SEC Doc Filr Page |
| 4 | 2026-06-11 | 2026-06-09 | 4 | 0001193125-26-267802 | View SEC Doc Filr Page |
| 4 | 2026-06-11 | 2026-06-09 | 4 | 0001193125-26-267797 | View SEC Doc Filr Page |
| 4 | 2026-06-11 | 2026-06-09 | 4 | 0001193125-26-267769 | View SEC Doc Filr Page |
| 4 | 2026-06-11 | 2026-06-09 | 4 | 0001193125-26-267766 | View SEC Doc Filr Page |